BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND FCGR2B, FCGR2, 2213, ENSG00000072694, CD32, CD32B, P31994, IGFR2, FCG2
14 results:

  • 1. Clinical impact of proteinuria on renal function and treatment outcomes in patients with radioiodine-refractory thyroid cancer treated with lenvatinib.
    Fukuda N; Toda K; Suto H; Oki R; Wang X; Urasaki T; Sato Y; Nakano K; Ono M; Tomomatsu J; Mitani H; Takahashi S
    Endocr J; 2024 Apr; 71(4):363-371. PubMed ID: 38296547
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Prognostic impact of splenic vessel involvement and tumor size in distal pancreatectomy for adenocarcinoma: a retrospective multicentric cohort study.
    Gantois D; Guilbaud T; Scemama U; Girard E; Picaud O; Lefevre M; Elgani M; Hamidou Z; Moutardier V; Balandraud P; Chirica M; Barbier L; Fuks D; Birnbaum DJ
    Langenbecks Arch Surg; 2022 Feb; 407(1):153-165. PubMed ID: 34373941
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Gene coexpression network approach to develop an immune prognostic model for pancreatic adenocarcinoma.
    Gu X; Zhang Q; Wu X; Fan Y; Qian J
    World J Surg Oncol; 2021 Apr; 19(1):112. PubMed ID: 33845841
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Identify potential clinical significance of long noncoding RNA forkhead box P4 antisense RNA 1 in patients with early stage pancreatic ductal adenocarcinoma.
    Liu XG; Xu H; Chen M; Tan XY; Chen XF; Yang YG; Lin MZ; Liu GH; Liang XL; Qian YB; Yuan GJ; Chen MQ; Li WT; Miao HL; Li MY; Liao XW; Dai W; Chen NP
    Cancer Med; 2020 Mar; 9(6):2062-2076. PubMed ID: 31991068
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The efficient profiling of serum N-linked glycans by a highly porous 3D graphene composite.
    Niu H; Li X; Peng J; Zhang H; Zhao X; Zhou X; Yu D; Liu X; Wu R
    Analyst; 2019 Sep; 144(17):5261-5270. PubMed ID: 31364612
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Risks of Breast, Ovarian, and Contralateral Breast cancer for BRCA1 and BRCA2 Mutation Carriers.
    Kuchenbaecker KB; Hopper JL; Barnes DR; Phillips KA; Mooij TM; Roos-Blom MJ; Jervis S; van Leeuwen FE; Milne RL; Andrieu N; Goldgar DE; Terry MB; Rookus MA; Easton DF; Antoniou AC; ; McGuffog L; Evans DG; Barrowdale D; Frost D; Adlard J; Ong KR; Izatt L; Tischkowitz M; Eeles R; Davidson R; Hodgson S; Ellis S; Nogues C; Lasset C; Stoppa-Lyonnet D; Fricker JP; Faivre L; Berthet P; Hooning MJ; van der Kolk LE; Kets CM; Adank MA; John EM; Chung WK; Andrulis IL; Southey M; Daly MB; Buys SS; Osorio A; Engel C; Kast K; Schmutzler RK; Caldes T; Jakubowska A; Simard J; Friedlander ML; McLachlan SA; Machackova E; Foretova L; Tan YY; Singer CF; Olah E; Gerdes AM; Arver B; Olsson H
    JAMA; 2017 Jun; 317(23):2402-2416. PubMed ID: 28632866
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The relationship between iodine intake and the risk of thyroid cancer: A meta-analysis.
    Cao LZ; Peng XD; Xie JP; Yang FH; Wen HL; Li S
    Medicine (Baltimore); 2017 May; 96(20):e6734. PubMed ID: 28514290
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Platinum-Based Chemotherapy Induces Methylation Changes in Blood DNA Associated with Overall Survival in Patients with Ovarian cancer.
    Flanagan JM; Wilson A; Koo C; Masrour N; Gallon J; Loomis E; Flower K; Wilhelm-Benartzi C; Hergovich A; Cunnea P; Gabra H; Braicu EI; Sehouli J; Darb-Esfahani S; Vanderstichele A; Vergote I; Kreuzinger C; Castillo-Tong DC; Wisman GBA; Berns EM; Siddiqui N; Paul J; Brown R
    Clin Cancer Res; 2017 May; 23(9):2213-2222. PubMed ID: 27663594
    [No Abstract]    [Full Text] [Related]  

  • 9. Molecular Pathways: Targeting DNA Repair Pathway Defects Enriched in Metastasis.
    Corcoran NM; Clarkson MJ; Stuchbery R; Hovens CM
    Clin Cancer Res; 2016 Jul; 22(13):3132-7. PubMed ID: 27169997
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Natural history and outcome in Chinese patients with gastroenteropancreatic neuroendocrine tumours: - a 17-year retrospective analysis.
    Chan DT; Luk AO; So WY; Kong AP; Chow FC; Ma RC; Lo AW
    BMC Endocr Disord; 2016 Feb; 16():12. PubMed ID: 26911576
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Human recombinant anti-thyroperoxidase autoantibodies: in vitro cytotoxic activity on papillary thyroid cancer expressing TPO.
    Rebuffat SA; Morin M; Nguyen B; Castex F; Robert B; Péraldi-Roux S
    Br J Cancer; 2010 Mar; 102(5):852-61. PubMed ID: 20145622
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcgamma receptors.
    Stavenhagen JB; Gorlatov S; Tuaillon N; Rankin CT; Li H; Burke S; Huang L; Vijh S; Johnson S; Bonvini E; Koenig S
    Cancer Res; 2007 Sep; 67(18):8882-90. PubMed ID: 17875730
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Differential expression of IGF components and insulin receptor isoforms in human seminoma versus normal testicular tissue.
    Neuvians TP; Gashaw I; Hasenfus A; Hacherhäcker A; Winterhager E; Grobholz R
    Neoplasia; 2005 May; 7(5):446-56. PubMed ID: 15967097
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Mortality among triazine herbicide manufacturing workers.
    MacLennan PA; Delzell E; Sathiakumar N; Myers SL
    J Toxicol Environ Health A; 2003 Mar; 66(6):501-17. PubMed ID: 12712593
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.